Curriculum Vitae
Full Name Sebastien HENRY
Position / Job Title Vice President, Program Management; Co-Founder
Affiliation Micron Biomedical, Inc.

Sebastien Henry is the Vice President, Program Management and a Co-Founder of Micron Biomedical, a clinical stage biopharmaceutical company on a rapid path to commercialize its proprietary applicator-free, dissolving, microneedle patch technology designed to achieve better health outcomes through enhanced therapeutic effects, simplified logistics, and improved patient compliance.

Micron’s technology has been successfully evaluated in a Phase 1 clinical trial for the administration of an FDA-approved seasonal influenza vaccine and is entering the clinical development stage for therapeutics and vaccines with funding from the Bill & Melinda Gates Foundation, UNICEF, the Centers for Disease Control and Prevention (CDC), and pharmaceutical companies.

Mr. Henry has 20 years of experience in the microneedle and medical device fields in various R&D and operations roles.

• J Arya, S Henry, H Kalluri, DC McAllister, WP Pewin, MR Prausnitz (2017) Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects, Biomaterials, 128:1-7.
• NG Rouphael, M Paine, R Mosley, S Henry, DV McAllister, H Kalluri, WP Pewin, PM Frew, T Yu. NJ Thornburg, S Kabbani, L Lai, EV Vassilieva, I Skountzou, RW Compans, MJ Mulligan, MR Prausnitz (2017) The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomized, partly blinded, placebo-controlled, phase 1 trial, The Lancet, 390:649-658.
• S Henry, DV McAllister, MG Allen, MR Prausnitz (1998) Microfabricated microneedles: A novel approach to transdermal drug delivery, Journal of Pharmaceutical Sciences, 87:922-925.